Our
Products
Bring cardiovascular images to life
ArtFun+
Measures new MRI imaging scores
IMAGEENS has developed ArtFun+, Europe’s first clinically validated software as a medical device for measuring novel MRI biomarkers based on arterial stiffness evaluation — a major risk factor for cardiovascular disease and a significant predictor of mortality.
ArtFun+ assists physicians in detecting the earliest signs of cardiovascular disease across large populations of at-risk and asymptomatic patients.
cardioinspect
Enables a personal analysis of CV age & risk
MAGEENS has developed CardioInspect, built on ArtFun+ biomarkers, to support cardiovascular check-ups.
CardioInspect helps clinicians initiate and monitor cardiovascular prevention by providing a personalized report that assesses cardiovascular age and risk, based on our proprietary data.
Label
Creates data catalogs
ready for AI training
IMAGEENS has developed Label, a technology that enables data owners to seamlessly structure and prepare their imaging datasets for AI training.
Label empowers healthcare institutions to unlock the full potential of multi-dimensional cardiovascular MRI data and accelerate AI development — as adopted by Europe’s largest medical imaging database (EDS/AP-HP).
